315.98USD-0.19%Mkt Cap: —P/E: 38.761d ago
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…
Industry Peers
Health Care Providers & ServicesKey Statistics
Company
Market Cap—
Enterprise Value72.48B $
Revenue (TTM)332.77B $
Gross Profit13.18B $
Net Income (TTM)2.62B $
Revenue/Share1715.73 USD
Last Price315.98 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees47.0K
CountryGB
SectorHealthcare
IndustryHealth Care Providers & Services
ISIN—
Valuation
P/E (Trailing)38.76
P/E (Forward)—
PEG—
EV/EBITDA13.07
EV/Revenue0.22
P/S—
P/B19.87
EPS (TTM)8.20
EPS (Forward)—
52W Range
298.5061% of range327.25
52W High327.25 USD
52W Low298.50 USD
Profitability
Gross Margin3.96%
Oper. Margin1.41%
EBITDA Margin1.67%
Profit Margin0.79%
ROE96.87%
ROA3.56%
Growth
Revenue Growth5.10%
Earnings Growth11.90%
Cash Flow & Leverage
Operating CF4.82B $
CapEx (TTM)—
FCF Margin0.61%
FCF Yield—
Net Debt11.65B $
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity446.52
Current Ratio0.94
Quick Ratio0.48
Book Value/Sh15.99 USD
Cash/Share14.75 USD
Dividends
Fwd Div Rate—
Trail. Div Rate2.350 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.211.93M
Float180.24M
Insiders4.31%
Institutions99.63%
Technical
SMA 50227.22 (+39.1%)
SMA 200198.00 (+59.6%)
Beta0.57
S&P 52W Chg18.16%
Avg Vol (30d)10.06K
Avg Vol (10d)875
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—